anthralin has been researched along with Inflammation in 15 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 The effect of topical arachidonic acid on anthralin inflammation was studied using sequential measurements of erythema (reflectance photometry) and oedema (calipers)." | 7.67 | Effect of arachidonic acid on anthralin inflammation. ( Lawrence, CM; Shuster, S, 1987) |
| "1 The effect of topical arachidonic acid on anthralin inflammation was studied using sequential measurements of erythema (reflectance photometry) and oedema (calipers)." | 3.67 | Effect of arachidonic acid on anthralin inflammation. ( Lawrence, CM; Shuster, S, 1987) |
| "Inflammatory linear verrucous epidermal nevus (ILVEN) is a rare and chronic skin disorder, which may trouble the patient considerably." | 2.67 | Treatment of inflammatory linear verrucous epidermal nevus. ( Rulo, HF; van de Kerkhof, PC, 1991) |
| "Psoriasis is a common, immune-mediated inflammatory skin disease characterized by red, heavily scaled plaques." | 1.42 | Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells. ( Broadhurst, D; Dunn, WB; Goodacre, R; Griffiths, CE; Hollywood, KA; Winder, CL; Xu, Y, 2015) |
| "Dithranol has been used to treat psoriasis for decades." | 1.33 | Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin. ( Dobo, E; Gulya, K; Orojan, I; Szigeti, C; Varszegi, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Hollywood, KA | 1 |
| Winder, CL | 1 |
| Dunn, WB | 1 |
| Xu, Y | 1 |
| Broadhurst, D | 1 |
| Griffiths, CE | 1 |
| Goodacre, R | 1 |
| Gábor, M | 1 |
| Orojan, I | 1 |
| Szigeti, C | 1 |
| Varszegi, S | 1 |
| Dobo, E | 1 |
| Gulya, K | 1 |
| Van der Vleuten, CJ | 1 |
| Gerritsen, MJ | 1 |
| De Jong, EM | 1 |
| Elbers, M | 1 |
| De Jongh, GJ | 1 |
| van de Kerkhof, PC | 3 |
| La, E | 1 |
| Muga, SJ | 1 |
| Locniskar, MF | 1 |
| Fischer, SM | 1 |
| Messer, G | 1 |
| Rupec, RA | 1 |
| Viluksela, M | 1 |
| Rulo, HF | 1 |
| Queille-Roussel, C | 1 |
| Duteil, L | 1 |
| de Mare, S | 1 |
| Happle, R | 1 |
| Whitefield, M | 1 |
| Leeder, GM | 1 |
| Mosedale, AR | 1 |
| Black, AK | 1 |
| Barr, RM | 1 |
| Wong, E | 1 |
| Brain, S | 1 |
| Greaves, MW | 1 |
| Dickinson, R | 1 |
| Shroot, B | 1 |
| Hensby, CN | 1 |
| Lawrence, CM | 1 |
| Shuster, S | 1 |
| Gawkrodger, DJ | 1 |
| Carr, MM | 1 |
| McVittie, E | 1 |
| Guy, K | 1 |
| Hunter, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis[NCT03348462] | Phase 4 | 20 participants (Actual) | Interventional | 2017-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for anthralin and Inflammation
| Article | Year |
|---|---|
Models of acute inflammation in the ear.
Topics: Alkynes; Animals; Anthralin; Arachidonic Acid; Cantharidin; Capsaicin; Carrageenan; Croton Oil; Derm | 2003 |
[Induced inflammation in normal human skin. I. Value, methods and results].
Topics: Anthralin; Croton Oil; Dermatitis; Drug Hypersensitivity; Humans; Inflammation; Skin Diseases; Skin | 1991 |
3 trials available for anthralin and Inflammation
| Article | Year |
|---|---|
A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris.
Topics: Adult; Aged; Anthralin; Capsules; Cell Differentiation; Cell Division; Epidermis; Female; Humans; Im | 1996 |
Treatment of inflammatory linear verrucous epidermal nevus.
Topics: Adolescent; Anthralin; Female; Humans; Inflammation; Isotretinoin; Nevus; Skin Neoplasms | 1991 |
Keratinocyte expression of MHC class II antigens in allergic sensitization and challenge reactions and in irritant contact dermatitis.
Topics: Anthralin; Dermatitis, Contact; Dinitrochlorobenzene; Female; Histocompatibility Antigens Class II; | 1987 |
10 other studies available for anthralin and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells.
Topics: Anthralin; Cell Line; Cell Proliferation; Gas Chromatography-Mass Spectrometry; Humans; Inflammation | 2015 |
Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin.
Topics: Animals; Anthralin; Dermatologic Agents; Face; Humans; Image Processing, Computer-Assisted; Inflamma | 2006 |
Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthralin; Blotting, Northern; Blotting, Western; Carcino | 1999 |
[Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning].
Topics: Acute-Phase Reaction; Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Autoimm | 2001 |
Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anthralin; Anti-Inflammatory Agents, Non- | 1991 |
Dithranol in the treatment of inflammatory linear verrucous epidermal nevus.
Topics: Adult; Anthralin; Humans; Inflammation; Male; Nevus; Skin Neoplasms | 1989 |
Inhibition of dithranol inflammation by free-radical scavengers.
Topics: Anthracenes; Anthralin; Inflammation; Vitamin E | 1985 |
Lipoxygenase products of arachidonic acid in human inflamed skin.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Anthralin; Arachidonic Acid; Arachidonic Acids; D | 1985 |
Effect of arachidonic acid on anthralin inflammation.
Topics: Administration, Topical; Adult; Aged; Anthralin; Arachidonic Acid; Arachidonic Acids; Diterpenes; Ed | 1987 |